BLRX

Bioline Rx Ltd ADR

May 21 • 04:00PM ET

2.86

+0.11 4.00 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: IMNN AVTX TNXP PALI BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.18	Insider Own	0.56%	Shs Outstand	4.35M	Perf Week	-6.54%
Market Cap	12.44M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	0.00%	Shs Float	4.33M	Perf Month	27.68%
Enterprise Value	6.86M	PEG	-	EPS next Q	-1.04	Inst Own	0.45%	Short Float	3.64%	Perf Quarter	-1.38%
Income	-1.30M	P/S	10.45	EPS this Y	-	Inst Trans	9.48%	Short Ratio	3.65	Perf Half Y	-10.90%
Sales	1.19M	P/B	0.68	EPS next Y	39.09%	ROA	-3.25%	Short Interest	0.16M	Perf YTD	3.25%
Book/sh	4.18	P/C	0.60	EPS next 5Y	-	ROE	-8.19%	52W High	7.77 -63.19%	Perf Year	-21.21%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	75.30% 66.78%	ROIC	-5.49%	52W Low	2.15 33.02%	Perf 3Y	-95.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	36.15%	Volatility	8.92% 8.44%	Perf 5Y	-97.69%
Dividend TTM	-	EV/Sales	5.77	EPS Y/Y TTM	96.05%	Oper. Margin	-871.39%	ATR (14)	0.22	Perf 10Y	-99.48%
Dividend Ex-Date	-	Quick Ratio	1.78	Sales Y/Y TTM	-95.92%	Profit Margin	-109.15%	RSI (14)	52.22	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.95	EPS Q/Q	78.83%	SMA20	-0.89%	Beta	1.41	Target Price	17.50
Payout	-	Debt/Eq	0.56	Sales Q/Q	-98.35%	SMA50	10.33%	Rel Volume	0.21	Prev Close	2.75
Employees	24	LT Debt/Eq	0.30	Earnings	May 27 BMO	SMA200	-9.74%	Avg Volume	43.20K	Price	2.86
IPO	Jul 25, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.87% -62.26%	Trades		Volume	9,125	Change	4.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)